ArticleAnnals of hematology2024
Development and validation of a novel risk stratification model and a survival rate calculator for diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study.
Qiaofeng Zhong et al.PubMed ↗Publisher ↗
No numbers read from the abstract.